Results 101 to 110 of about 45,735 (205)

Nephrolithiasis induced end stage renal disease in patients on hemodialysis in Baghdad (A Multicenter study) [PDF]

open access: yesAl Ameen Journal of Medical Sciences, 2016
Background: Kidney stones are the third most common disease of the urinary system. Nephrolithiasis still remains underappreciated cause of end stage renal disease.
Ali J. Hashim Al Saedi   +2 more
doaj  

Comparison of nephrolithiasis prevalence in two bottlenose dolphin (Tursiops truncatus) populations

open access: yesFrontiers in Endocrinology, 2013
In humans, ammonium urate nephrolithiasis is rare in the Western hemisphere and more common in Japan and developing countries. Among a variety of risk factors, insulin resistance has been associated with urate nephrolithiasis in people.
Cynthia Rowe Smith   +8 more
doaj   +1 more source

Metabolic syndrome and the risk of calcium stones [PDF]

open access: yes, 2017
Sakhaee et al in this issue have investigated whether the risk of the common calcium nephrolithiasis is associated with the metabolic syndrome (MS).
Adams-Huet, Beverley   +6 more
core  

Addition of Phentermine‐Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double‐Blind Randomized Clinical Trial

open access: yesObesity, Volume 34, Issue 3, Page 524-536, March 2026.
ABSTRACT Objective This study compared the effects of phentermine‐topiramate‐ER (mid‐dose 7.5/46 mg) versus placebo on weight loss and cardiovascular disease (CVD) risk outcomes when used as an adjunct to a digitally enhanced lifestyle intervention (DELI).
Alejandro Campos   +15 more
wiley   +1 more source

Prevalence and related factors of nephrolithiasis among medical staff in Qingdao, China: a retrospective cross-sectional study

open access: yesBMC Nephrology
Background Certain occupations may predispose individuals to urolithiasis, a multi-factorial disease. The study aimed to evaluate the prevalence and related factors of nephrolithiasis in medical staff in Qingdao, China.
Lei Guo   +7 more
doaj   +1 more source

Objective assessment of functional and motor-cognitive outcomes among asymptomatic primary hyperparathyroidism patients undergoing parathyroidectomy using wearable technologies: a pilot study towards better informed clinical decision-making [PDF]

open access: yes, 2017
For the past 40 years, most patients with Primary Hyperparathyroidism (PHPT) have presented with the asymptomatic form of PHPT. Despite the dominance of the asymptomatic PHPT phenotype, current National Institutes of Health (NIH) indications for ...
Siddiqi, Noreen
core  

Beyond the Norm: Atypical Manifestations of Aspergillosis

open access: yesRespirology Case Reports, Volume 14, Issue 3, March 2026.
We describe a rare case of Aspergillus infection presenting as a chest mass, underscoring the diagnostic challenges of fungal diseases in immunocompromised patients and highlighting the importance of considering unusual manifestations in clinical practice.
Leila Zahiri   +5 more
wiley   +1 more source

Evaluation of the chemical composition of nephrolithiasis using dual-energy CT in Southern Chinese gout patients

open access: yesBMC Nephrology, 2019
Background A study to evaluate the prevalence of uric acid (UA) nephrolithiasis with dual-energy CT (DECT) and explore the risk factors for kidney stones in primary gout patients.
Zhao-Xia Li   +5 more
doaj   +1 more source

Rare Neurosarcoidosis Involvements

open access: yesRespirology Case Reports, Volume 14, Issue 3, March 2026.
Neurosarcoidosis is a rare manifestation of systemic sarcoidosis. Establishing a diagnosis can be challenging for clinicians, particularly in cases of isolated neurosarcoidosis. Here, we present nine patients with rare manifestations of neurosarcoidosis. ABSTRACT Neurosarcoidosis is a rare manifestation of systemic sarcoidosis. Establishing a diagnosis
Gülce Cansu Serin   +3 more
wiley   +1 more source

Alemtuzumab Induction in Septuagenarians Undergoing Deceased Donor Kidney Transplantation

open access: yesClinical Transplantation, Volume 40, Issue 3, March 2026.
ABSTRACT Introduction The anti‐CD52 monoclonal antibody alemtuzumab is used as an induction agent in kidney transplantation (KT) but remains understudied in septuagenarian recipients. The study purpose was to analyze the safety and efficacy of single‐dose alemtuzumab induction in septuagenarian deceased donor (DD) KT recipients.
David I. Harriman   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy